#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Allogenic stem cell transplantation Antiphospholipid antibodies Metachromatic leukodystrophy Small cell lung cancer Autoimmune disorder Cognitive disorder Peritoneal mesothelioma malignant Spinal cord injury Germ cell cancer Hypereosinophilic syndrome Vaginal cancer Corneal neovascularisation Encephalitis autoimmune Spinal muscular atrophy Squamous cell carcinoma of the hypopharynx More trials…

    Learn about Rare Diseases

    Glycogen storage disease type II – Life with Disease Antithrombin III deficiency – Life with Disease Lymphangiosarcoma Prolymphocytic leukaemia Primary immunodeficiency syndrome Leiomyosarcoma recurrent – Treatment Marginal zone lymphoma refractory – Diagnostics Burkitt’s lymphoma Rett syndrome – Basic Information Mitochondrial myopathy – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lsta1 Pariglasgene Brecaparvovec SRSD107 PIPOTIAZINE HLX43 Oric-114 Xp-Dc+Tl+Klh Triptorelin Pamoate Aspergillus Fumigatus Ropeginterferon Alfa-2B Flecainide Acetate Dexamethasone Acetate [Al[18F]F]Fapi-74 Radotinib Dihydrochloride Mepolizumab Ab-729 Ferric Derisomaltose Streptococcus Agalactiae Emactuzumab Fosfomycin Trometamol More therapies…

    Learn about Your Condition

    Bladder cancer H1N1 influenza Tinnitus Apheresis Glomerulonephritis Diabetic gastroparesis Cervix carcinoma stage I Breast angiosarcoma Chronic coronary syndrome Trigeminal neuralgia Leber's congenital amaurosis Primary adrenal insufficiency Chronic kidney disease Varicella Pyoderma gangrenosum More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Major depression

  • Long‑Term Safety, Tolerability and Efficacy of Azetukalner in Patients with Major Depressive Disorder

    Recruiting

    3 1 1
    Investigated Drugs:
    • Azetukalner
    Finland Germany Poland Romania Slovakia Spain

  • A study to evaluate the effectiveness and safety of DT-101 in adults with major depressive disorder

    Recruiting

    2 1
    Investigated Diseases:
    • Major depression
    Bulgaria Czechia Poland

  • A Study of SPT-300 Compared to Placebo for Adults with Major Depressive Disorder with or without Anxious Distress

    Recruiting

    2 1
    Bulgaria Czechia Germany Hungary Poland Romania +1

  • A study of azetukalner compared to placebo for adults with moderate-to-severe major depressive disorder

    Recruiting

    3 1
    Investigated Drugs:
    • Azetukalner
    Czechia Finland Germany Poland Romania Slovakia +1

  • A study testing intranasal esketamine compared to midazolam for rapidly reducing symptoms of major depressive disorder in adolescents with suicidal thoughts or behavior

    Recruiting

    3 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Esketamine
    • Midazolam
    Hungary Italy Romania Spain

  • A Study of Brexanolone Caprilcerbate for Adults with Major Depressive Disorder With or Without Anxious Distress

    Recruiting

    2 1 1
    Bulgaria Czechia Germany Hungary Poland Romania +1
1 2 3 … 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!